Ezra, a healthcare AI startup focused on early cancer detection through full-body MRI screening, has received FDA clearance for its latest AI technology, Ezra Flash. This proprietary AI enhances the quality of MR images, allowing for faster and more cost-effective scans. Ezra plans to launch the world's first 30-minute full-body MRI scan using this technology.
Emi Gal, the founder and CEO of Ezra, expressed excitement about the AI's potential to make scans more affordable and accessible. Ezra Flash is the first AI system to be applied across all three crucial components of the cancer screening process: imaging, analysis, and reporting. It improves MR image quality, assists in prostate image analysis, and facilitates the translation of radiology reports.
Ezra Flash has received FDA clearance for brain imaging and has been trained using the company's extensive MRI dataset. The clearance marks a significant milestone in medical imaging, as Ezra aims to shift from using MRI for diagnosis to proactive monitoring and early cancer detection before symptoms appear.
Early cancer detection significantly improves survival rates, and Ezra's scans have helped members identify potential cancer and other clinically significant diseases. Currently available in select cities, Ezra plans to expand its services to more locations in the second half of 2023.
Click here to read the original news story.